Tuesday, June 1, 2010

ProUroCare Medical, Inc. (PUMD.OB) to Present Investigational ProUroScan™ Technology at the Annual American Urological Association Meeting

ProUroCare Medical, Inc., a leading provider of innovative medical imaging products, recently announced the company will make a presentation at the American Urological Association (AUA) 2010 Annual Scientific Meeting in San Francisco. The conference runs from May 29 until June 1. The company will showcase its investigational prostate imaging system, the ProUroScan™, to help educate urologists about the concept and potential of elasticity imaging of the prostate gland.

Founded in 1902, The AUA is the foremost professional association for the advancement of urologic patient care. The ProUroScan™ system is currently under review for market clearance by the Food and Drug Administration (FDA). The product is intended to be used to produce an elasticity image of the prostate as an aid in documenting abnormalities of the prostate that are initially identified by digital rectal examination.

Rick Carlson, chief executive officer of ProUroCare Medical, Inc., commented, “The AUA Annual Meeting is a perfect venue for physicians to try the ProUroScan system on simulated prostate models.”

About QualityStocks:

QualityStocks’ Small Cap Stock Newsletter is a free service that collects data from hundreds of Small-Cap online Investment Newsletters into one free Daily Newsletter Report.

Sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net

Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net

No comments: